Megola, Inc. (OTCPK:MGON) entered into definitive agreement to acquire License of Intellectual Property, Product Lines, Manufacturing & Other Assets of Medesol Global Inc. for $0.25 million on September 20, 2022. Medesol Global Inc receives 25,000 Restricted PFD D shares with a stated value of $10 per share. Megola's BOD will also determine future royalties to Medesol Global per specific product sales generated.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0049 USD | +4.48% | 0.00% | +104.17% |
1st Jan change | Capi. | |
---|---|---|
+104.17% | 1.37M | |
-17.42% | 39.45B | |
+13.34% | 26.31B | |
-25.78% | 6.15B | |
+6.56% | 6.02B | |
-5.36% | 3.06B | |
+8.48% | 2.48B | |
-9.44% | 1.91B | |
+32.96% | 951M | |
-3.06% | 620M |
- Stock Market
- Equities
- MGON Stock
- News Megola, Inc.
- Megola, Inc. entered into definitive agreement to acquire License of Intellectual Property, Product Lines, Manufacturing & Other Assets of Medesol Global Inc. for $0.25 million.